Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4053698rdf:typepubmed:Citationlld:pubmed
pubmed-article:4053698lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:4053698lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:4053698lifeskim:mentionsumls-concept:C0013072lld:lifeskim
pubmed-article:4053698lifeskim:mentionsumls-concept:C0014806lld:lifeskim
pubmed-article:4053698lifeskim:mentionsumls-concept:C0518948lld:lifeskim
pubmed-article:4053698pubmed:issue5lld:pubmed
pubmed-article:4053698pubmed:dateCreated1985-12-19lld:pubmed
pubmed-article:4053698pubmed:abstractTextIn a double-blind controlled study the treatment of erythromycin 500 mg twice daily for seven days was compared with erythromycin 500 mg twice daily for four days in 73 men and women with uncomplicated genito-urinary chlamydia trachomatis infections. At the start of the treatment, 34 of 42 men (81%) and 15 of 31 women (48%) had symptoms suggesting the presence of chlamydial infections. There was a significantly higher bacteriological cure rate with the seven-days treatment in both men and women compared with the four days treatment at the second control visit two weeks after the start of the treatment (p less than 0.0005). The bacteriological cure rate of the women was higher than that of the men, but the results for men and women did not differ significantly. It is concluded that a four day treatment with erythromycin 500 mg twice daily can not be recommended, whereas 500 mg twice daily for seven days was shown to be effective, especially in women.lld:pubmed
pubmed-article:4053698pubmed:languageenglld:pubmed
pubmed-article:4053698pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4053698pubmed:citationSubsetIMlld:pubmed
pubmed-article:4053698pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4053698pubmed:statusMEDLINElld:pubmed
pubmed-article:4053698pubmed:monthOctlld:pubmed
pubmed-article:4053698pubmed:issn0907-8916lld:pubmed
pubmed-article:4053698pubmed:authorpubmed-author:PetersenC SCSlld:pubmed
pubmed-article:4053698pubmed:authorpubmed-author:WormA MAMlld:pubmed
pubmed-article:4053698pubmed:authorpubmed-author:AvnstorpCClld:pubmed
pubmed-article:4053698pubmed:issnTypePrintlld:pubmed
pubmed-article:4053698pubmed:volume32lld:pubmed
pubmed-article:4053698pubmed:ownerNLMlld:pubmed
pubmed-article:4053698pubmed:authorsCompleteYlld:pubmed
pubmed-article:4053698pubmed:pagination269-71lld:pubmed
pubmed-article:4053698pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:4053698pubmed:meshHeadingpubmed-meshheading:4053698-...lld:pubmed
pubmed-article:4053698pubmed:meshHeadingpubmed-meshheading:4053698-...lld:pubmed
pubmed-article:4053698pubmed:meshHeadingpubmed-meshheading:4053698-...lld:pubmed
pubmed-article:4053698pubmed:meshHeadingpubmed-meshheading:4053698-...lld:pubmed
pubmed-article:4053698pubmed:meshHeadingpubmed-meshheading:4053698-...lld:pubmed
pubmed-article:4053698pubmed:meshHeadingpubmed-meshheading:4053698-...lld:pubmed
pubmed-article:4053698pubmed:meshHeadingpubmed-meshheading:4053698-...lld:pubmed
pubmed-article:4053698pubmed:meshHeadingpubmed-meshheading:4053698-...lld:pubmed
pubmed-article:4053698pubmed:meshHeadingpubmed-meshheading:4053698-...lld:pubmed
pubmed-article:4053698pubmed:meshHeadingpubmed-meshheading:4053698-...lld:pubmed
pubmed-article:4053698pubmed:year1985lld:pubmed
pubmed-article:4053698pubmed:articleTitleErythromycin against Chlamydia trachomatis infections. A double blind study comparing 4- and 7-day treatment in men and women.lld:pubmed
pubmed-article:4053698pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:4053698pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:4053698pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4053698lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4053698lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4053698lld:pubmed